Friday’s dip buying is not proving particularly lucrative for European investors as stocks have given back earlier gains to trade broadly flat on the day.
Given the seesaw price action over the last week, you’d be forgiven for thinking we’re due a day in the green. And early in the day, that’s the way we were headed. But indices quickly turned south after the open and have gradually eaten away at early gains to trade flat on the day.
Investors are clearly still anxious about the Omicron variant for obvious reasons, despite anecdotal evidence suggesting symptoms are less severe than feared. Higher levels of transmission are a worry but, ultimately, it will come down to the effectiveness of vaccines, which is the overriding concern currently.
Heading into the weekend, when we could get more information on the new strain, it’s natural that we’re seeing more caution. A slew of negative data releases over the course of the morning doesn’t help lift sentiment and may be behind the gradual reversal we’ve seen in European markets.
Taper And Rate Hike Expectations
It’s clear from comments this week by Fed Chair Jerome Powell and his colleagues that the plan has changed recently. The central bank now intends to taper faster, raise rates sooner and, of course, retire the use of the word ‘transitory.’ But Omicron could complicate efforts further just as the economic data was starting to catch up. A strong report today leaves the Fed well and truly backed into a corner.
CBRT Interventions As Successful As Its Interest Rate Experiment
The CBRT is back in intervention mode, addressing “unhealthy price formations.” Based on the movements in the lira, which remains marginally off its all-time lows, it would appear the central bank’s interventions are about as effective as its monetary policy experiment. The unconventional approach to managing the lira hasn’t been particularly effective in the past and there’s no reason to expect it to work out any better this time. Especially in the current global economic and inflationary environment.
This article is for general information purposes only. It is not investment advice or a solution to buy or sell securities. Opinions are the authors; not necessarily that of OANDA Corporation or any of its affiliates, subsidiaries, officers or directors. Leveraged trading is high risk and not suitable for all. You could lose all of your deposited funds.
